Feedback Share Discussion Threads

[andya99] 04/12/2015 16:32

Dr Balaji Ganeshan, Director of New Business at Feedback Plc is to present a paper at the prestigious Society of Cardiac MR (SCMR) in January 2016. The paper’s abstract title is ‘CMR myocardial texture analysis tracks different etiologies of left ventricular hypertrophy’, and could lead to a new application in the field of cardiology for TexRAD following a study undertaken at UCL in collaboration with London Heart Hospital.

[kenwrong] 30/11/2015 14:27

Norbert I know probably as much about Feedback as you do. Additional fund raising to finance growth for a company of this size is probably a likely event at some stage, but the big names signing up for jvs and forming separate companys with Feedback could also see other forms of financing too - and even a bid. Either way the ip looks strong enough to carry early stage investors through to a decent profit.

[norbert colon] 25/11/2015 13:14

Ken

I get the feeling you know more about FDBK than I do - how do you foresee the company financing itself in the short / medium term until commercialisation of TexRad etc kicks in, specifically given their depleted cash pile?

[kenwrong] 25/11/2015 10:26

It is on the Alliance twitter feed?

[zeuss1] 23/11/2015 18:15

Arguably this has to be the most significant step yet for Feedback and Texrad software. The global market value for Non-Small Cell Lung Cancer (NSCLC) treatment will increase from $6.9bn in 2014 to $10.9bn by 2021, representing a Compound Annual Growth Rate (CAGR) of 8.5%, - source GBI Research. Integrating Feedback's TexRAD texture analysis software into Alliance's lung cancer imaging service is a major step forward and exposes this tiny little company to this fast-growing market. It is also the latest in a long line of developments, including the recent Stone Checker and Prostate Checker jv's. For investors wondering about the valuation of this company, I would suggest you view newsflow, results and rate of progress over the summer against a £4.5m market cap.

[the stigologist] 23/11/2015 13:10

Alliance don't even bother including this on their website or twitter

hxxp://www.alliancemedical.co.uk/news

[the stigologist] 23/11/2015 13:08

MoU aren't worth didley

[lr2] 23/11/2015 12:36

Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce that it has signed a Memorandum of Understanding with Alliance Medical Group ("Alliance") with the intention of integrating Feedback's TexRAD texture analysis software into Alliance's lung cancer imaging service. Although the technical discussions are at a very early stage, this is considered by Feedback to be potentially of great significance as regards the future commercialization of TexRAD software. Alliance and Feedback plan to undertake a multi-centre imaging research study to assess the use of TexRAD in lung cancer, with the eventual aim of gaining National Institute for Health and Care Excellence ("NICE") approval for TexRAD to be used in the Lung Cancer pathway. An update on the progress of the technical discussions will be provided with Feedback's interim results announcement in February 2016.

In January 2015, NHS England selected a collaborative network led by Alliance to provide PET-CT scanning services across 30 locations in England following a competitive tender process. By December 2015 Alliance and its partners in the network will be providing a substantial amount of PET-CT imaging service in England. Published research studies have suggested that assessing patients already diagnosed with lung cancer by using TexRAD texture analysis software applied on the staging PET-CT imaging examination could potentially be a major application for TexRAD and provide valuable information to clinicians. In April 2015, Feedback announced a clinical adoption study was being commenced to assess the potential for TexRAD's use in a multi-disciplinary team setting specifically focused on non-small cell lung cancer. This was followed in October 2015 by the announcement that the research arm of NHS England had 'alerted' on the potential application of TexRAD in assessing patients with lung cancer.

Dr. Balaji Ganeshan, CEO of TexRAD Ltd and Director of New Business at Feedback Plc commented:
"We are delighted to be working with Alliance who are Europe's leading independent provider of imaging services. The planned research study in lung cancer will be an important step towards the future commercialization of TexRAD."
Charles Niehaus, Group CMO, COO, Alliance Medical Group commented:

"Alliance and clinicians of the Collaborative Network are excited to be working with Feedback Plc to integrate the TexRAD software within Alliance's lung cancer service across the imaging network. We anticipate this will enhance lung cancer diagnosis and prognosis within the NHS leading to improved patient management and valuable information for both Alliance and Feedback."

[the stigologist] 10/11/2015 10:47

Massively overvalued and the pump and dump merchant Frauddy seems to be moving on elsewhere

[norbert colon] 06/11/2015 09:55

NAV of the company is tiny now the cash has been depleted - they are going to need cash moving forward and it will be interested to see if / when a placing occurs. I have sold the last of my remaining shares today at a very good profit but will look to potentially reinvest as I think there is lots of potential. Good luck to all.

[kenwrong] 06/11/2015 09:31

..no sooner said than share price pops back above 2p again!

[someuwin] 06/11/2015 09:13

But it sounds like they are expecting less sales and more expenditure going forward...

"In order to generate optimum value for shareholders we shall be looking to support our collaboration partners and invest further in our newly-formed joint venture companies. The year ahead will also see the Company selling fewer research versions of TexRAD as we focus on setting up more joint venture companies and collaborations targeting specific applications for TexRAD's clinical use to provide the foundation for TexRAD's future commercial success."

[kenwrong] 06/11/2015 08:57

Well the losses have increased but the revenues are nearly at £400k, and will no doubt be higher in the current year. With all the progress with Texrad I do not understand the fall in the share price this morning, especially as the market cap is so tiny?

[blueball] 06/11/2015 08:28

Careful the results are not good.

[norbert colon] 04/11/2015 12:00

I believe the AGM is soon to be announced - I hope that a number of investors attend. I certainly intend to.

[lr2] 03/11/2015 18:43

Feedback PLC – ICENI Centre & ISLCRS study to investigate whether textural features of rectal cancer on Magnetic Resonance can predict long term survival

Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long term survival in locally advanced rectal cancer patients.

[andya99] 03/11/2015 18:14

hxxp://www.pharmatimes.com/Article/15-11-02/New_initiative_to_boost_UK_pathology_research.aspx


"Last month Cancer Research UK awarded Queens University Belfast £3.9 million to develop new pathology and image analysis techniques for solid tumours.

This includes research to improve cancer diagnosis through tissue imaging, biomarker discovery and clinical trials, and the cash will also underpin the next generation of scientists with a Clinical Fellowship programme in molecular pathology, the charity said."

[zeuss1] 26/10/2015 07:58

The results of this study seem to have been missed here. Although this took place in July it provides yet more anecdotal evidence of the growing importance attached to texture analysis, of which Feedback (TexRAD) seems to have cornered the market.

- On July 20th 2015, Feedback plc announced the successful completion of a large evaluation of TexRAD CT texture analysis (CTTA) as a pre-therapy imaging biomarker in 241 metastatic renal (kidney) cell cancer (m-RCC) patients treated with anti-angiogenic therapy (AAT – drugs that block cancer blood-vessel growth).

The research study was led by Dr. Andrew Smith (Associate Professor in Radiology and Director of Radiology Research) along with colleagues from the University of Mississippi Medical Center, Jackson, Mississippi, USA (UMMC).

Specifically the results from this large study demonstrated that TexRAD texture analysis on conventional CT imaging acquired before m-RCC patients underwent AAT was a very strong predictor of overall survival at 2 years. Dr. Smith and colleagues further demonstrated that in a multivariate model comprising of known clinical biomarkers in this cancer population, TexRAD CTTA additionally demonstrated to be a strongly independent predictor of overall survival. The authors have developed a “new prognostic risk index” comprising of TexRAD CTTA and other known clinical factors which has demonstrated superior accuracy in predicting patient survival and classified patients into low, medium and high-risk groups with strong statistical significance. Dr. Smith and colleagues also concluded that pre-therapy TexRAD CTTA is a significant prognostic marker in patients with m-RCC treated with AAT.

On October 7th-11th, 2015 Dr Andrew Smith presented the data from this large patient study (n=241) on the use of TexRAD texture analysis on CT scans in predicting survival in secondary kidney cancer patients treated with anti-vascular drugs.

The presentation at the Society of Computed Body Tomography and Magnetic Resonance (SCBT-MR) Conference was awarded the Best Junior Researcher Presentation. Slides here hxxp://www.branduk.net/feedback-plc-presentation-of-study-results/

[blueball] 12/10/2015 08:32

I would be happy with 5p by xmas.

[blueball] 11/10/2015 20:35

Afraid its last weeks news.

[andya99] 11/10/2015 17:52

Zak Mir's Bull Call Of The Day No.1:Feedback: 5p In View After Latest Gap Higher

hxxp://www.shareprophets.com/views/15572/zak-mir-s-bull-call-of-the-day-no1feedback-5p-in-view-after-latest-gap-higher

[blueball] 09/10/2015 20:15

Will have a listen over the weekend.

[britstox] 09/10/2015 17:10

What a great pod cast

[lr2] 09/10/2015 16:08

Thanks for posting Ken. Feedback chat starts around 24:30. Have re-posted link as yours has been modified by Advfn.

[kenwrong] 09/10/2015 15:56

Just caught the latest interview with Dr Ganeshan after the announcements on this week. Well worth a listen. hxxps://audioboom.com/boos/3672264-318-teathers-financial-plc-and-feedback-plc